Is a complete LXEO research report available?

No complete published report is available for Lexeo Therapeutics, Inc. (LXEO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · USD

$3.12

+0.25 (+8.7%)· Recorded snapshot

Market cap	256M
Net income (ttm)	-87.3M
EPS (ttm)	-$1.15
Shares out	82M
Volume	993,699
Beta	1.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -87.3M
EPS (ttm): -$1.15
Market cap: 256M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001907108
Company name	Lexeo Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	52886X107
Earnings date	2026-11-09
Earnings time	bmo
Employees	63
Employees change	2
Employees growth	3.28%
Enterprise value	$51.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2023-11-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US52886X1072
Last 10-K release date	2026-03-30
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$256M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$3.12
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	LXEO
U.S. state	New York
Website	https://www.lexeotx.com

Metric

Value

Amount currency

USD

CIK code

0001907108

Company name

Lexeo Therapeutics, Inc.

Country

United States

Country code

CUSIP number

52886X107

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

3.28%

Enterprise value

$51.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2023-11-03

Is primary listing

Yes

Is SPAC

ISIN number

US52886X1072

Last 10-K release date

2026-03-30

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$256M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$3.12

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

LXEO

U.S. state

New York

Website

https://www.lexeotx.com

Metric	Value
Earnings yield	-36.72%
FCF / EV yield	-223%
FCF yield	-36.25%
P/B ratio	0.96x
Price / tangible book value	1.04x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-36.72%

FCF / EV yield

-223%

FCF yield

-36.25%

P/B ratio

0.96x

Price / tangible book value

1.04x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.4M
ROA	-27.59%
ROA (5Y)	-37.1%
ROCE	-39.76%
ROE	-46.76%
ROE (5Y)	-67.2%
ROIC	-30.56%

Metric

Value

Profit per employee

$-1.4M

ROA

-27.59%

ROA (5Y)

-37.1%

ROCE

-39.76%

ROE

-46.76%

ROE (5Y)

-67.2%

ROIC

-30.56%

Metric	Value
EPS growth quarters	5
EPS growth years	3
Net income growth quarters	4
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-331,000
Depreciation and amortization	$613,000
EBIT	$-95.1M
EBITDA	$-94.5M
EPS	$-1.15
FCF per share	$-1.08
Financing cash flow	$170.7M
Free cash flow	$-88.7M
Free cash flow minus SBC	$-102.5M
Gross profit	$-66.6M
Investing cash flow	$-25M
Net borrowing	$-515,000
Net cash flow	$57.4M
Net income	$-87.3M
Operating cash flow minus SBC	$-102.2M
Operating income	$-95.1M
Stock-based compensation	$13.8M

Metric

Value

Capital expenditures

$-331,000

Depreciation and amortization

$613,000

EBIT

$-95.1M

EBITDA

$-94.5M

EPS

$-1.15

FCF per share

$-1.08

Financing cash flow

$170.7M

Free cash flow

$-88.7M

Free cash flow minus SBC

$-102.5M

Gross profit

$-66.6M

Investing cash flow

$-25M

Net borrowing

$-515,000

Net cash flow

$57.4M

Net income

$-87.3M

Operating cash flow minus SBC

$-102.2M

Operating income

$-95.1M

Stock-based compensation

$13.8M

Metric	Value
Book value per share	$2.99
Debt / equity	0.03
Interest coverage	-1,302.97
Long-term assets	$37M
Long-term liabilities	$4.1M
Net cash (debt)	$204.9M
Net cash / market cap	83.74%
Net cash growth	65.26%
Net debt / equity	-0.87
Piotroski F-Score	1
Property, plant and equipment	$7.9M
Shareholders' equity	$235.1M
Tangible book value	$235.1M
Tangible book value per share	$2.99
Total assets	$254.9M
Total cash	$211.7M
Total debt	$6.8M
Total liabilities	$19.8M
WACC	12.93%

Metric

Value

Book value per share

$2.99

Debt / equity

0.03

Interest coverage

-1,302.97

Long-term assets

$37M

Long-term liabilities

$4.1M

Net cash (debt)

$204.9M

Net cash / market cap

83.74%

Net cash growth

65.26%

Net debt / equity

-0.87

Piotroski F-Score

Property, plant and equipment

$7.9M

Shareholders' equity

$235.1M

Tangible book value

$235.1M

Tangible book value per share

$2.99

Total assets

$254.9M

Total cash

$211.7M

Total debt

$6.8M

Total liabilities

$19.8M

WACC

12.93%

Metric	Value
Current assets	$217.9M
Current liabilities	$15.7M
Current ratio	13.89
Net working capital	$-6.8M
Quick ratio	13.57
Working capital	$202.2M

Metric

Value

Current assets

$217.9M

Current liabilities

$15.7M

Current ratio

13.89

Net working capital

$-6.8M

Quick ratio

13.57

Working capital

$202.2M

Metric	Value
Buyback yield / dilution	-113.19%
Dividend yield	0%
Shareholder yield	-113.19%

Metric

Value

Buyback yield / dilution

-113.19%

Dividend yield

Shareholder yield

-113.19%

Metric	Value
150-day SMA	$4.72
1D price change	8.71%
1M price change	-6.95%
1M total return	-6.95%
1W price change	1.99%
1W total return	1.99%
1Y price change	-68.7%
1Y return CAGR	-68.72%
1Y total return	-68.7%
20-day SMA	$3.03
200-day SMA	$5.26
3M price change	-31.1%
3M total return	-31.1%
50-day SMA	$3.84
50-day SMA vs 200-day SMA	50under200
52-week high	$10.99
52-week high date	2025-12-23
52-week low	$2.55
52-week low date	2026-10-19
6M price change	-45.24%
6M total return	-45.24%
All-time high	$22.33
All-time high date	2024-01-18
All-time low	$1.45
All-time low date	2025-04-07
Average true range (ATR)	$0.25
Average volume	1.6M
Beta (1Y)	2.79
Beta (2Y)	2.37
Beta (5Y)	1.64
Change from 52-week high	-71.61%
Change from 52-week low	22.35%
Change from all-time high	-86.21%
Change from all-time low	112.41%
Change from open	10.25%
Day's gap	-1.39%
Dollar volume	$3.1M
High price	$3.13
Low price	$2.81
Monthly RSI	36.44
Open price	$2.83
Position in 52-week range	96.92%
Premarket change	2.44%
Premarket close	$2.87
Premarket price	$2.94
Premarket volume	508
Previous close	$2.87
Price vs 150-day SMA	-34.72%
Price vs 20-day SMA	1.75%
Price vs 200-day SMA	-41.4%
Price vs 50-day SMA	-19.69%
Relative volume	0.62
Return from IPO open	-68.61%
Return from IPO price	-72.89%
RSI	46.26
Sharpe ratio	-1.33
Sortino ratio	-1.7
Volume	993.7K
Weekly RSI	34.51
YTD price change	-68.98%
YTD total return	-68.98%

Metric

Value

150-day SMA

$4.72

1D price change

8.71%

1M price change

-6.95%

1M total return

-6.95%

1W price change

1.99%

1W total return

1.99%

1Y price change

-68.7%

1Y return CAGR

-68.72%

1Y total return

-68.7%

20-day SMA

$3.03

200-day SMA

$5.26

3M price change

-31.1%

3M total return

-31.1%

50-day SMA

$3.84

50-day SMA vs 200-day SMA

50under200

52-week high

$10.99

52-week high date

2025-12-23

52-week low

$2.55

52-week low date

2026-10-19

6M price change

-45.24%

6M total return

-45.24%

All-time high

$22.33

All-time high date

2024-01-18

All-time low

$1.45

All-time low date

2025-04-07

Average true range (ATR)

$0.25

Average volume

1.6M

Beta (1Y)

2.79

Beta (2Y)

2.37

Beta (5Y)

1.64

Change from 52-week high

-71.61%

Change from 52-week low

22.35%

Change from all-time high

-86.21%

Change from all-time low

112.41%

Change from open

10.25%

Day's gap

-1.39%

Dollar volume

$3.1M

High price

$3.13

Low price

$2.81

Monthly RSI

36.44

Open price

$2.83

Position in 52-week range

96.92%

Premarket change

2.44%

Premarket close

$2.87

Premarket price

$2.94

Premarket volume

508

Previous close

$2.87

Price vs 150-day SMA

-34.72%

Price vs 20-day SMA

1.75%

Price vs 200-day SMA

-41.4%

Price vs 50-day SMA

-19.69%

Relative volume

0.62

Return from IPO open

-68.61%

Return from IPO price

-72.89%

RSI

46.26

Sharpe ratio

-1.33

Sortino ratio

-1.7

Volume

993.7K

Weekly RSI

34.51

YTD price change

-68.98%

YTD total return

-68.98%

Metric	Value
Float	51.2M
Float percentage	62.42%
Shares change (QoQ)	5.47%
Shares change (YoY)	113.19%
Shares held by insiders	0.39%
Shares held by institutions	78.69%
Shares outstanding	82M
Short % of float	37.58%
Short % of shares	23.46%
Short ratio	13.9 days

Metric

Value

Float

51.2M

Float percentage

62.42%

Shares change (QoQ)

5.47%

Shares change (YoY)

113.19%

Shares held by insiders

0.39%

Shares held by institutions

78.69%

Shares outstanding

82M

Short % of float

37.58%

Short % of shares

23.46%

Short ratio

13.9 days

Lexeo Therapeutics, Inc. (LXEO)

Price

Financial snapshot

Fair-value bridge

Latest news · LXEO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LXEO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LXEO

Frequently asked questions